The influence of fetal loss on the presence of fetal cell microchimerism: A systematic review
Open Access
- 4 November 2003
- journal article
- review article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 48 (11) , 3237-3241
- https://doi.org/10.1002/art.11324
Abstract
Objective Fetal cells enter the maternal circulation during most pregnancies. Their persistence for years occurs in only some women and has been associated with several autoimmune diseases such as systemic sclerosis. The objective of this study was to determine whether pregnancy history influences the persistence of fetal microchimeric cells. Methods We reviewed all reports of studies on fetal cell microchimerism, defined as male DNA in maternal tissue, that describe individual pregnancy histories, disease diagnoses, and microchimerism status. The total numbers of pregnancies, births, and sons, the history of fetal loss (spontaneous abortion and elective termination), and the presence of a maternal autoimmune disease were tested as factors potentially associated with persistent microchimerism. Results One hundred twenty‐four subjects from 11 studies met the inclusion criteria. Only fetal loss was significantly associated with the presence of microchimerism (odds ratio 2.4, 95% confidence interval 1.2–6.0). Conclusion These results suggest that fetomaternal cell trafficking following fetal loss may be important for the engraftment of microchimeric cells in maternal tissue. This may be due to an increased amount of fetomaternal transfusion or to transfer of a cell type that is more likely to engraft. We recommend that investigators in future studies on microchimerism report detailed pregnancy information, since these data are critical for the understanding of factors that influence the development of fetal cell microchimerism.Keywords
This publication has 24 references indexed in Scilit:
- Cervical cancer and microchimerismPublished by Wolters Kluwer Health ,2003
- Significant fetal cell microchimerism in a nontransfused woman with hepatitis C: Evidence of long-term survival and expansionHepatology, 2002
- Male microchimerism in healthy women and women with scleroderma: cells or circulating DNA? A quantitative answerBlood, 2002
- Microchimerism of presumed fetal origin in thyroid specimens from women: a case-control studyThe Lancet, 2001
- Y chromosome microchimerism in Sjögren's syndromeAnnals of the Rheumatic Diseases, 2001
- Evidence of Fetal Microchimerism in Hashimoto's ThyroiditisJournal of Clinical Endocrinology & Metabolism, 2001
- Significant fetal-maternal hemorrhage after termination of pregnancy: Implications for development of fetal cell microchimerismAmerican Journal of Obstetrics and Gynecology, 2001
- Identification of Fetal DNA and Cells in Skin Lesions from Women with Systemic SclerosisNew England Journal of Medicine, 1998
- Microchimerism and HLA-compatible relationships of pregnancy in sclerodermaThe Lancet, 1998
- Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum.Proceedings of the National Academy of Sciences, 1996